Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G1 cell cycle arrest and apoptosis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples